Prof. Rory Collins
Principal Investigator and Chief Executive of the UK Biobank
Head of Nuffield Department of Population Health and BHF Professor of Medicine and Epidemiology at University of Oxford
講師プロフィール
Rory Collins is an epidemiologist who studies prevention and treatment of chronic diseases. He was the founding Head of Oxford University’s Nuffield Department of Population Health.
During the past 40 years, he has conducted large randomised trials which have demonstrated that clot-dissolving and clot-preventing treatments during a heart attack more than halve mortality, and that lowering LDL-cholesterol with statins safely reduces cardiovascular death and disability.
He has led UK Biobank since 2005. Involving 500,000 participants, it is the largest deeply-characterized prospective study globally, available for health research. About 20,000 researchers worldwide actively use it, generating ~5000 papers in 2024 alone.

